This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Hang on a second…

This CME Activity has expired and is no longer available for credit.

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Sweet Dreams - Improving Outcomes for Patients With Insomnia

Sweet Dreams - Improving Outcomes for Patients With Insomnia

Format

Interactive Monograph

Time to Complete

1 hour

Released

September 29, 2015

Expires

September 29, 2016
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CE for Nurses

Accredited Provider

Jointly provided by Postgraduate Institute for Medicine and MedEdicus LLC

Commercial Supporter

This activity is supported by an independent educational grant from Merck & Co, Inc.

Program Description

Insomnia is very common in primary care. It is important to recognize and treat it because of its adverse effects on physical and mental health, daily function, and quality of life. Recent developments in nosology, the understanding of the neurobiology of wake-sleep function, and pharmacotherapy options have implications for improving diagnosis and optimizing patient care. This activity provides practical case-based strategies illustrating optimal management of patients with insomnia.

Intended Audience

This activity has been designed to meet the educational needs of primary care physicians, nurse practitioners, physician assistants, and registered nurses involved in the management of patients with insomnia.

Educational Objectives

After completing this activity, the participant will demonstrate the ability to:

  • Review the mechanism of the sleep/wake cycle as it relates to insomnia
  • Proactively evaluate patients for insomnia
  • Evaluate the mechanisms, efficacy, and safety of therapeutic choices for insomnia
  • Apply appropriate management strategies in patients with insomnia

Conflict of Interest Disclosure Policy

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Larry Culpepper, MD, MPH
Chief, Department of Family Medicine
Professor and Chairman of Family Medicine
Boston University School of Medicine
Boston, Massachusetts

Dr Culpepper had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant Fees: Astra Zeneca; Forest Labs; Lundbeck A/S; Merck & Co, Inc; Shire PLC, Inc; Takeda Pharmaceuticals Inc. Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers' bureaus): Elsevier Press. Ownership Interest: M 3 Information, LLC. Royalty: UpToDate, Oxford University Press. Other: Editor in Chief of the Primary Care Companion for CNS Disorders.

Ruth Benca, MD, PhD
Professor, Departments of Psychology and Psychiatry
University of Wisconsin – Madison
Madison, Wisconsin

Dr Benca had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant Fees: Janssen Pharmaceuticals, Inc; Jazz Pharmaceuticals, Inc; Merck & Co, Inc. Contracted Research: Merck & Co, Inc.

Angela Golden, DNP, FNP-C, FAANP
AANP Past President
Owner and NP
NP from Home, LLC
Munds Park, Arizona

Dr Golden had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant Fees: Merck & Co, Inc.

Planners' and Managers' Disclosures

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; Judi Smelker-Mitchek, RN, BSN; and Jan Schultz, RN, MSN, CHCP, and the following MedEdicus editors and planners, Cheryl Guttman and Cynthia Tornallyay, RD, MBA, CHCP, hereby state that they or their spouse/life partner did not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and MedEdicus. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Postgraduate Institute for Medicine.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a post-test score of 75% or better is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can then access at any time.

If you have any questions relating to the certification of this activity, please contact Postgraduate Institute for Medicine via www.pimed.com.

For any CME-related questions, please call (201) 799-4827 or email cmequestions@haymarketmedical.com.
Add to Queue